The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient

被引:31
|
作者
Gopalakrishna, Ajay [1 ]
Longo, Thomas A. [1 ]
Fantony, Joseph J. [1 ]
Owusu, Richmond [2 ]
Foo, Wen-Chi [3 ]
Dash, Rajesh [3 ]
Inman, Brant A. [1 ]
机构
[1] Duke Univ, Med Ctr, Div Urol, Durham, NC 27710 USA
[2] Univ Calif San Diego, Dept Urol, San Diego, CA 92103 USA
[3] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
来源
BMC UROLOGY | 2016年 / 16卷
基金
美国国家卫生研究院;
关键词
FISH; Cytology; Bladder cancer; Sensitivity; Specificity; Spectrum effects; SPECTRUM BIAS; CARCINOMA; INTEROBSERVER; EXPRESSION; GUIDELINES; MANAGEMENT; CYTOLOGY; GENDER; STAGE;
D O I
10.1186/s12894-016-0147-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Spectrum effects refer to the phenomenon that test performance varies across subgroups of a population. When spectrum effects occur during diagnostic testing for cancer, difficult patient misdiagnoses can occur. Our objective was to evaluate the effect of test indication, age, gender, race, and smoking status on the performance characteristics of two commonly used diagnostic tests for bladder cancer, urine cytology and fluorescence in situ hybridization (FISH). Methods: We assessed all subjects who underwent cystoscopy, cytology, and FISH at our institution from 2003 to 2012. The standard diagnostic test performance metrics were calculated using marginal models to account for clustered/repeated measures within subjects. We calculated test performance for the overall cohort by test indication as well as by key patient variables: age, gender, race, and smoking status. Results: A total of 4023 cystoscopy-cytology pairs and 1696 FISH-cystoscopy pairs were included in the analysis. In both FISH and cytology, increasing age, male gender, and history of smoking were associated with increased sensitivity and decreased specificity. FISH performance was most impacted by age, with an increase in sensitivity from 17 % at age 40 to 49 % at age 80. The same was true of cytology, with an increase in sensitivity from 50 % at age 40 to 67 % at age 80. Sensitivity of FISH was higher for a previous diagnosis of bladder cancer (46 %) than for hematuria (26 %). Test indication had no impact on the performance of cytology and race had no significant impact on the performance of either test. Conclusions: The diagnostic performance of urine cytology and FISH vary significantly according to the patient demographic in which they were tested. Hence, the reporting of spectrum effects in diagnostic tests should become part of standard practice. Patient-related factors must contextualize the clinicians' interpretation of test results and their decision-making.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The diagnostic accuracy of urine-based tests for bladder cancer varies greatly by patient
    Ajay Gopalakrishna
    Thomas A. Longo
    Joseph J. Fantony
    Richmond Owusu
    Wen-Chi Foo
    Rajesh Dash
    Brant A. Inman
    [J]. BMC Urology, 16
  • [2] IMPACT OF RENAL FUNCTION ON THE DIAGNOSTIC ACCURACY OF URINE-BASED TESTS FOR THE DETECTION OF BLADDER CANCER
    Henenlotter, Joeg
    Witstruk, Mark
    Wagner, Viktoria
    Kuehs, Ursula
    Gakis, Georgios
    Todenhoefer, Tilman
    Alloussi, Saladin
    Aufderklamm, Stefan
    Stenzl, Arnulf
    Schwentner, Christian
    [J]. JOURNAL OF UROLOGY, 2011, 185 (04): : E497 - E498
  • [3] Urine-based oncological diagnostic for bladder carcinoma
    Ruebben, H.
    [J]. UROLOGE, 2009, 48 (06): : 597 - 597
  • [4] Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer
    Charpentier, Marine
    Gutierrez, Charly
    Guillaudeux, Thierry
    Verhoest, Gregory
    Pedeux, Remy
    [J]. CANCERS, 2021, 13 (07)
  • [5] Urine-based assays for bladder cancer
    Getzenberg, RH
    [J]. LABORATORY MEDICINE, 2003, 34 (08) : 613 - 617
  • [6] Urine-based assays for the detection of bladder cancer
    Villicana, Patrick
    Whiting, Bryant
    Goodison, Steve
    Rosser, Charles J.
    [J]. BIOMARKERS IN MEDICINE, 2009, 3 (03) : 265 - 274
  • [7] Urine-based tumour diagnostics for bladder cancer
    Knuechel, R.
    Lindemann-Docter, K.
    [J]. UROLOGE, 2009, 48 (06): : 598 - +
  • [8] The use of urine-based biomarkers in bladder cancer
    Grossman, HB
    Blute, ML
    Dinney, CPN
    Jones, JS
    Liou, LS
    Reuter, VE
    Soloway, MS
    [J]. UROLOGY, 2006, 67 (3A) : 62 - 64
  • [9] Urine-based markers of angiogenesis in bladder cancer
    Becker, M.
    Tilki, D.
    Szarvas, T.
    Ruebben, H.
    Erguen, S.
    [J]. UROLOGE, 2009, 48 (06): : 609 - +
  • [10] Urine-based molecular biomarker signatures for bladder cancer
    Zhao, Zhixin
    Chang, Amy
    Xiang, Binggang
    Xie, Feng
    Wang, Xiaohong
    Zhou, Kemin
    Yu, Jianjun
    Du, Pan
    Jia, Shidong
    [J]. CANCER RESEARCH, 2020, 80 (16)